| HCC | Hepatocellular carcinoma |
| ICIs | Immune checkpoint inhibitors |
| TME | Tumor microenvironment |
| CTLA-4 | Cytotoxic-T-lymphocyte-associated protein 4 |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed cell death ligand 1 |
| EV | Extracellular vesicle |
| TEXs | Tumor-cell-derived exosomes |
| NK | Nature killer |
| DCs | Dendritic cells |
| HMGB1 | High mobility group box1 |
| DEXs | DC-derived exosomes |
| SD | Spleen deficiency |
| DC-TEX | TEX-pulsed DCs |
| DEX-AFP | AFP-expressing DCs |
| AD5 | Type V adenovirus |
| CAR-T | Chimeric antigen receptor T |
| TAMs | Tumor-associated macrophages |
| MSCs | Mesenchymal stem cells |
| BMSCs | Bone MSCs |
| ELISA | Enzyme-linked immunosorbent assay |
| CTCs | Circulating tumor cells |